Answers are grounded in this paper and cite their sources.
At JADPRO Live 2023, presenters emphasized the importance of increasing colorectal cancer screening in high-risk groups, reviewed guidelines in the adjuvant and metastatic setting, and outlined clinical and molecular profiles to consider when discussing and determining treatment options with patients.
No takes yet. Share an insight, caveat, or question.
Morgan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: